Elaine Caughey

Chief Business Officer, Kymera Therapeutics.

Companies

Kymera TherapeuticsChief Business Officer Jun 21, 2021 to Mar 3, 2023¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Kymera Therapeutics KYMR18,986 shares²$2.1M at $108.02Mar 2, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 2, 2023Sold 164 shares at $31.40 of Kymera Therapeutics²
Mar 2, 2023Sold 550 shares at $30.88 of Kymera Therapeutics²
Mar 1, 2023Granted 10,557 shares of Kymera Therapeutics²
Mar 1, 2022Granted 7,000 shares of Kymera Therapeutics³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARKymera Therapeutics, Chief Business Officer
2
SEC EDGARKymera Therapeutics shares after the filing of Mar 2, 2023
3
SEC EDGARForm 4 filed Mar 3, 2022